Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
French luxury groups to highlight sector's resilience as demand holds up for now
-
Analysis-Europe Inc's wage hikes alarm investors as worries about recession grow
-
Analysis-Europe Inc's wage hikes alarm investors as worries about recession grow
-
Analysis-Europe Inc's wage hikes alarm investors as worries about recession grow
-
Explainer-U.S. marijuana pardons help thousands, leave others in prison
-
Apple (AAPL): Bernstein's Sacconaghi 'Cautious' on iPhone 14 Cycle, Valuation
-
Form D/A Sanford C. Bernstein &
-
FVCBankcorp, Inc. Appoints Marc N. Duber to Board of Directors
-
These are Top Tech Stocks to Own as Selected by Bernstein's Toni Sacconaghi
-
Peter Templeton Named President & CEO of U.S. Green Building Council and Green Business Certification Inc.
-
All Star Healthcare Solutions Welcomes CIO, Announces Divisional VP Promotion
-
Bernstein's Impression of Tesla's (TSLA) Optimus Robot: 'Why Humanoid?'
-
PayPal's (PYPL) Braintree Likely Worth $15bn-$20bn - Bernstein
-
'One of the Best Compounding Stories Out There': Bernstein Starts Airbnb (ABNB) at Outperform
-
Tesco lowers profit sights as British shoppers face winter crunch
-
After-Hours Movers: Emerson Gains on Asset Sale Talk, PG&E Falls on Block Sale
-
Bernstein Starts Airbnb Inc. (ABNB) at Outperform
-
Factbox-U.S. abortion restrictions mount after overturn of Roe v. Wade
-
Hippie, fugitive, deadbeat dad buried lovingly by his children in his bookshelves
-
Balto Announces Partnership with Five9 to Empower Agents with Conversation Excellence
-
Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference
-
SQZ Biotechnologies (SQZ) Reports Preclinical Research Demonstrating AAC Platform's Potential
-
SQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform’s Potential as an Effective Red Blood Cell-Derived Immunotherapy
-
Tesla (TSLA) Now 'Unlikely' to Hit Its 50% Delivery Growth Goal for 2022 - Analyst
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane Ian death toll climbs to 83, officials defend response
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Hurricane-ravaged Florida, Carolinas face daunting recovery
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
-
After Hurricane Ian's deadly wrath, Florida, Carolinas begin recovery
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
-
Florida, Carolinas count the cost of one of the worst U.S. hurricanes
